Sionna Therapeutics SION
NASDAQ SION
$5.10 -0.16 (-3.04%)
At close: Oct 1, 2026 · 4:00 PM EDT

Sionna Therapeutics (SION) Return on Equity [ROE] (2025 - 2026)

Updated

Sionna Therapeutics (SION) posted Return on Equity [ROE] of -35.18% for Q2 2026, down 12.94 percentage points from -22.24% a year earlier and down 6.34 percentage points from the prior quarter.

Analysis

Sionna Therapeutics (SION) Return on Equity [ROE] (2025 - 2026) Analysis & Trends

For FY2025, Sionna Therapeutics' Return on Equity [ROE] came in at -105.77%.

  • The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q1 2025.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -28.84% (Q1 2026), -24.08% (Q4 2025) and -21.66% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Sionna Therapeutics 237.56 Mn 237.56 Mn - -35.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.18%
Mar 31, 2026 -28.84%
Dec 31, 2025 -24.08%
Sep 30, 2025 -21.66%
Jun 30, 2025 -22.24%
Mar 31, 2025 -71.29%
API Access

Sionna Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=SION&period=max&api_key=YOUR_API_KEY